Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, April 14, 2022
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
Wed, April 13, 2022
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
Matthew Sykes Maintained (TWST) at Hold with Decreased Target to $55 on, Apr 13th, 2022
Matthew Sykes of Goldman Sachs, Maintained "Twist Bioscience Corporation" (TWST) at Hold with Decreased Target from $105 to $55 on, Apr 13th, 2022.
Matthew has made no other calls on TWST in the last 4 months.
There are 2 other peers that have a rating on TWST. Out of the 2 peers that are also analyzing TWST, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Puneet Souda of "SVB Leerink" Maintained at Hold with Decreased Target to $70 on, Monday, February 7th, 2022
This is the rating of the analyst that currently disagrees with Matthew
- Luke Sergott of "Barclays" Maintained at Buy with Decreased Target to $75 on, Monday, February 7th, 2022
